Skip to main content
. 2019 Jul 19;160(11):2600–2617. doi: 10.1210/en.2019-00410

Figure 11.

Figure 11.

Substantial reduction of human PCC primary culture viability (n = 5) by cabozantinib, entinostat, and niraparib, but not temozolomide, at 72 h of treatment. The arithmetic means and all single values of five human PCC primary cultures from five patients are shown. *Statistically significant different results in comparison with the DMSO control (P < 0.05).